United Kingdom · Operations · C-Suite (20+ years)

Chief Development Officer

Here is the whole job, in plain words. What it is, a real day, what you decide, how you're judged, how people get here and where they go next. Then the part no course gives you: twelve AI tutors who learn your work.

Experience bandC-Suite (20+ years)
Reports toChief Executive Officer (CEO) or Board of Directors
UK framework levelUsually an executive or board-level role

Also advertised as Chief Medical Officer · Head of Clinical Development · Executive Vice President, Clinical Operations

Built on an analysis of 43,079 real UK job descriptions · grounded in qualifications employers recognise

Start with a free Future Fluency check, tuned to Chief Development Officer

Ten quick questions, one per Future Fluency, asked against this role rather than a generic one. About five minutes, and no card.

Start the check, free

1What this role really is

This isn't just a big job; it's *the* job if you want to shape the future of our clinical pipeline and, honestly, the company itself. You'll be the ultimate voice for clinical development, setting the enterprise-wide strategy that decides which promising medicines make it to patients. It's about leading a massive organisation, navigating complex regulatory landscapes, and convincing investors that our vision is sound. Think of yourself as the architect of our clinical future, accountable for everything from early-stage trials to successful drug approvals.

2What you'd actually use

The tools this job runs on, and how well you'd need to know each one.

Veeva Vault CTMSStrategic

Overseeing the strategic direction, selection, and enterprise-wide integration of CTMS platforms, ensuring they support global operational efficiency and data visibility for the entire portfolio.

Medidata Rave EDCStrategic

Governing enterprise-wide data standards, approving EDC vendor selection, and ensuring data capture strategies align with regulatory requirements and analysis needs across the portfolio.

Veeva Vault eTMFStrategic

Setting the overall TMF strategy for the organisation, ensuring enterprise-wide inspection readiness, and managing key vendor relationships to maintain regulatory compliance globally.

Power BI / Tableau / SpotfireStrategic

Defining key portfolio-level performance metrics, interpreting high-level data trends, and presenting strategic insights from dashboards to the executive leadership team and Board to drive critical decisions.

Anaplan / Oracle EPM / SAP S/4HANA (Finance Modules)Expert

Building and managing the multi-million-pound departmental/portfolio budgets, conducting complex scenario planning, and rigorously defending financial forecasts to the Board and investors.

3What you get to decide, and how that grows

Power in a job isn't your title. It's what you're allowed to decide. Here's how it grows as you move up.

The choice	Coming in	Where you are now	The step above
Clinical Development Strategy & Pipeline Prioritisation	N/A	N/A	N/A
Major Regulatory Submissions & Interactions	N/A	N/A	N/A
Clinical Development Budget Allocation	N/A	N/A	N/A
Organisational Design & Leadership Appointments	N/A	N/A	N/A

4How you'll be judged

The scoreboard, honestly: the hard targets, how often each one is actually looked at, and the quiet human signals that never make it onto a dashboard.

Clinical Pipeline Progression Rate

The percentage of clinical programmes that successfully advance from one development phase to the next (e.g., Phase I to Phase II, Phase II to Phase III).

Target · Achieve >80% progression rate for pivotal programmes.

If we started with 5 Phase II programmes, and 4 successfully moved into Phase III within the year, that's an 80% progression rate. This shows we're picking the right candidates and executing well.

Key Regulatory Submission & Approval Timelines

The average time taken from the final database lock to a major regulatory submission (e.g., NDA, BLA) and then to market approval, compared to industry benchmarks.

Target · Achieve submission and approval timelines within 90% of industry best-in-class benchmarks.

If the industry average for a similar drug approval is 12 months post-submission, we'd aim for 10.8 months or less. This reflects efficiency and strong regulatory relationships.

Clinical Development Budget Adherence

The variance between the approved annual clinical development budget (often multi-million £) and the actual spend across the entire portfolio.

Target · Maintain overall budget variance at <5% annually.

If the annual budget for clinical development is £100M, actual spend should be between £95M and £105M. This shows tight financial control at an enterprise level.

R&D Return on Investment (ROI)

A high-level measure of the financial return generated from our clinical development investments, typically calculated based on projected peak sales of approved products.

Target · Demonstrate a positive and increasing trend in R&D ROI year-over-year, aiming for >15%.

If we invested £500M in R&D over 5 years and the approved drugs are projected to generate £1BN in net present value, that's a 100% ROI. You're looking for strong, sustainable returns.

Investor & Board Confidence

How confident our investors and Board of Directors are in our clinical development strategy, pipeline, and execution capabilities.

Positive feedback from Board meetings, favourable analyst reports, successful capital raises, stable or increasing stock price following clinical updates, proactive consultation on strategic decisions.

Regulatory Agency Relationships

The quality and effectiveness of our relationships with key global regulatory bodies.

Successful pre-submission meetings, constructive dialogue during inspections, absence of critical findings in audits, ability to influence regulatory guidance where appropriate, clear and timely feedback from agencies.

Organisational Talent & Leadership Pipeline

The strength of the clinical development leadership team and the pipeline of future leaders within the organisation.

High retention rate of key clinical development leaders, successful internal promotions to senior roles, positive results from leadership 360-degree feedback, a clear succession plan for critical roles.

Scientific Reputation & External Influence

Our standing within the scientific and medical community, and our ability to influence the broader clinical development landscape.

Invitations to speak at major industry conferences, publications in high-impact journals, strong relationships with Key Opinion Leaders (KOLs), participation in industry working groups, positive media coverage of our scientific advancements.

5Would you like it

The honest version. What people enjoy, and what grinds them down.

What people enjoy

Shaping the Future of Medicine

You'll spend your days making high-level strategic decisions on our pipeline, evaluating new therapeutic areas, and deciding which innovative technologies to invest in. It's about seeing the big picture and making choices that could impact millions of lives.

Leading the decision to pivot our research focus into a novel gene therapy area, knowing it's a multi-year, multi-million-pound bet that could revolutionise treatment for a rare disease.

Leading a World-Class Organisation

You'll be mentoring, coaching, and empowering a large team of VPs and Directors, fostering a culture of excellence and innovation. Your impact is through the thousands of people you lead, ensuring they have the resources and direction to succeed.

Developing a new leadership programme for your VPs, or personally intervening to unblock a major cross-functional issue that's holding back a critical programme.

High-Stakes Impact & Accountability

Every decision you make has multi-million-pound implications and directly affects patient outcomes and shareholder value. You'll be presenting to the Board, engaging with investors, and navigating complex regulatory negotiations. It's intense, but incredibly rewarding when it pays off.

Successfully defending our clinical strategy to a room full of skeptical investors, leading to a significant capital raise that funds our next wave of innovation.

What frustrates people

The sheer weight of regulatory bureaucracy and the time it takes to get anything approved, even when it's clearly beneficial for patients.
Managing the expectations of investors who often want immediate results, while knowing that drug development is a long, arduous process.
The political manoeuvring required to get alignment across different executive functions (e.g., R&D, Commercial, Finance) on critical strategic decisions.
The emotional toll of failed trials, where years of work and hope for patients don't pan out, and having to communicate that news to the organisation and the market.

What this role does not give you

A predictable 9-to-5 schedule; this is a 24/7 accountability role.
The ability to avoid difficult conversations or unpopular decisions.
A quiet, behind-the-scenes existence; you'll be a public face of the company.
Guaranteed success; the risks in drug development are enormous, and failure is a constant possibility.

6Who you work with

This role directly impacts the company's valuation, market position, and long-term viability. You're responsible for the entire clinical pipeline, from early-stage proof-of-concept to post-market surveillance. Your decisions dictate our R&D spend, our regulatory success, and our ability to deliver on our mission. Frankly, if clinical development doesn't perform, the company doesn't perform.

Inside the business

Chief Executive Officer (CEO)
Board of Directors
Chief Financial Officer (CFO)
Chief Scientific Officer (CSO)
Chief Commercial Officer (CCO)
General Counsel (Legal)
Head of Human Resources

Outside the business

Investors and Financial Analysts
Regulatory Bodies (e.g., MHRA, EMA, FDA)
Key Opinion Leaders (KOLs) and Scientific Advisors
Patient Advocacy Groups
Major Contract Research Organisations (CROs)
Media and Public Relations

7What you need before you start

Not a wish list. The things you would be expected to already have.

A proven track record of 15+ years in clinical operations and development leadership roles, with significant experience at VP or SVP level within a pharmaceutical or biotechnology company.
Demonstrated success in leading global clinical programmes from early-stage development through to successful regulatory submission and approval (e.g., NDA, BLA).
Extensive experience in managing large, multi-functional clinical development organisations (100+ people, including leaders of leaders).
Deep understanding of global regulatory landscapes and a history of successful interactions with major health authorities.
Proven ability to manage multi-million-pound clinical development budgets and deliver programmes within financial targets.

8What to practise next

Where the job is going, and what to do about it starting this week.

Integrated Clinical Data Ecosystems

The future demands a seamless flow of data across EDC, CTMS, eTMF, RWE, and digital health platforms. Siloed systems are inefficient and risky. You'll need to drive the vision for a unified, intelligent data ecosystem.

Data Lake/Warehouse Architecture · API Integration Strategies · Data Governance & Quality Frameworks

This quarter: Review our current clinical data architecture with your IT and Biometrics leads, identifying key integration challenges.
Next 6 months: Champion a strategic initiative to develop a roadmap for a fully integrated clinical data ecosystem.
Next 12 months: Secure budget and resources for key integration projects, focusing on high-impact areas like RWE and DCT data streams.

Quick win: Insist on a unified dashboard that pulls key metrics from all major clinical systems (CTMS, EDC, eTMF) into one view for your executive reporting.

9Staying current once you are in

What people here do to keep up

Active participation in major industry forums and conferences (e.g., DIA, SCOPE, BIO), presenting on strategic topics and engaging in panel discussions.
Serving on advisory boards for industry organisations or academic institutions, influencing the broader clinical development landscape.
Mentoring rising talent within the organisation and the wider industry, sharing your expertise and shaping future leaders.
Engaging in continuous learning on emerging technologies (AI, digital health) and evolving regulatory frameworks through executive education programmes or specialised courses.

10How the AI economy is changing work like this

Before we ask anything of you, here's what we can already say about AI and work of this kind:

The new skill this role is being asked for: AI-Driven Drug Development & Real-World Evidence (RWE) Integration

AI is rapidly transforming every stage of drug development, from target identification to patient stratification and clinical trial design. Regulators are increasingly accepting RWE for label expansions and post-market surveillance. Companies that master this will significantly accelerate development and gain market advantage.

We'll only ever tell you what we can actually back up. No hype, no scare tactics.

The rising capability

Zavmo analysis

What's rising in its place

This is where the work is heading, and the higher pay with it. Get fluent here and the shift stops being a threat and starts being your edge.

AI-Driven Drug Development & Real-World Evidence (RWE) Integration

AI is rapidly transforming every stage of drug development, from target identification to patient stratification and clinical trial design. Regulators are increasingly accepting RWE for label expansions and post-market surveillance. Companies that master this will significantly accelerate development and gain market advantage.

Generative AI for Protocol Optimisation
Predictive Analytics for Trial Success
RWE Data Source Integration
Ethical AI Governance

Decentralised Clinical Trials (DCT) at Scale & Digital Health Integration

The pandemic accelerated the shift towards DCTs, which offer benefits in patient access, diversity, and efficiency. Mastering the operational and regulatory complexities of truly decentralised global trials, and integrating digital health technologies, will be crucial for future success.

Virtual Trial Design & Execution
Wearable Devices & Remote Patient Monitoring
Regulatory Pathways for Digital Endpoints
Patient Engagement in DCTs

What you’ll use

Skills this role draws on

Technical

Enterprise Clinical Development Strategy
Global Regulatory Affairs & Health Authority Relations
Portfolio Risk Management
Investor Relations & Public Speaking
M&A Due Diligence & Integration

The pathway

How you actually get there, here

How you become one varies far more by country than what one does. This is the UK route. Most people take one of these ways in; the right one depends on where you're starting from.

1
Internal Promotion from VP/SVP, Clinical Operations
3-5 years as VP/SVP
Skills to master
- Enterprise-level strategic planning, Board engagement, investor relations, multi-functional leadership across all clinical development disciplines.
You're ready to move on when
- Successful leadership of a major therapeutic area or global clinical programme portfolio.
- Demonstrated ability to influence executive-level decisions and contribute to corporate strategy.
- Proven track record of building and leading high-performing leadership teams.
- Strong relationships with key internal and external stakeholders, including regulators and KOLs.
2
Chief Development Officer / Head of Clinical Development at a Smaller Biotech
5-8 years in a similar C-suite role
Skills to master
- Full P&L ownership, direct Board interaction, capital raising experience, building a clinical organisation from the ground up.
You're ready to move on when
- Successful leadership of a clinical development function through at least one major regulatory submission and approval.
- Experience operating with significant autonomy and accountability in a fast-paced environment.
- Ability to attract and retain top talent with limited resources.
- Strong external network within the biotech and investor communities.
3
Chief Medical Officer (CMO) or Senior Medical Director (if MD)
5-10 years in senior medical leadership
Skills to master
- Deep medical expertise, clinical trial design, medical affairs strategy, patient advocacy, safety oversight.
You're ready to move on when
- Board certification in a relevant medical specialty and extensive clinical practice experience.
- Leadership of medical affairs and clinical development teams.
- Strong reputation as a medical expert within the industry and with regulatory bodies.
- Demonstrated ability to bridge scientific innovation with clinical execution.

11Where this role leads

The long view:This role is a launchpad for the highest levels of leadership in the life sciences. It's demanding, but the opportunity to leave a lasting legacy—by bringing transformative medicines to patients and building a world-class organisation—is unparalleled. We're looking for someone ready to seize that challenge.

Pay & demand

Pay and demand for this role will appear here, each figure traced to a named authoritative source (e.g. the ONS Annual Survey of Hours and Earnings, under the Open Government Licence). We don’t show numbers we can’t attribute.

The ten Future Fluencies

Zavmo analysis

The credential is what you can do today. These are what keep you valuable.

A qualification proves you can do the job as it's defined today. These ten are what decide whether you're still the obvious person for it in five years. They're the capabilities employers are now writing into senior roles faster than people are learning them. Zavmo weaves them through whatever you study, so you come out with both: the credential and the fluency.

The highlighted ones are the Fluencies your role leans on hardest, from how Chief Development Officer is actually changing. In about two minutes, the free confidence check asks where you stand on each of the ten. That's the whole check, and it's what makes the plan yours rather than generic.

12The team that's yours

No two people are taught the same way. This is one-to-one, not one-to-many.

Zavmo is a hyper-personalised AI learning platform. Twelve virtual tutors, each with a different way of teaching, and one orchestration agent that picks the right one for the moment. So every single lesson is shaped around you, your role, and the way you learn. Not a course everyone sits through. A conversation built for you, and no one else.

…and nine more, matched to you after your first chat. Meet all twelve

Start free and meet yours

13What it feels like

A conversation, not a course

Because your tutor knows your role, your projects and your last session, learning sounds like this. And it's different for every single person:

Clinical skills in healthcareLevel 5

Applied to your work in Chief Development Officer

This unit aims to enable learners to understand roles, responsibilities and healthcare needs of individuals. Learners will assess, monitor, review and undertake clinical activities and lead practice in the development of clinical skills.

How the thinking builds

Remember
Understand
Apply
Analyse
Evaluate
Create

An illustration of a Zavmo lesson, built from this role’s own route. The unit, its objective and every criterion above are the awarding body’s own words, not an example.

One to one, not one to many

No two people run this the same way

A course is written once and handed to everyone. This is assembled around you, and keeps changing as it learns you. Five things it reads, and what each one changes.

Your actual work Every lesson is taught against a live piece of your own work, not a worked example from a textbook.
What you already know The first conversation finds your starting point, so you skip what you can already do and spend the time on what you cannot.
The conditions you learn under Not a learning-styles quiz. The evidence does not support those. The dimensions the research does back, read once and used to shape the plan.
How far you got last time It picks up mid-thought. The tutor knows what you said, what you struggled with, and what it asked you to try.
Which tutor suits the moment Twelve of them, each for a different kind of thinking. The one who walks you through a first idea is not the one who stress-tests it.

See how you learn, free. Eight questions, no sign-up. A directional taster; the diagnostic inside Zavmo goes deeper and keeps adapting.

DemonstrateIllustration

Evidenced on your work in Chief Development Officer

You do not finish by watching something. You finish by showing it on the work you already do, against the measures this job is judged on.

Clinical Pipeline Progression RateThe percentage of clinical programmes that successfully advance from one development phase to the next (e.g., Phase I to Phase II, Phase II to Phase III).If we started with 5 Phase II programmes, and 4 successfully moved into Phase III within the year, that's an 80% progression rate. This shows we're picking the right candidates and executing well.Achieve >80% progression rate for pivotal programmes.
Key Regulatory Submission & Approval TimelinesThe average time taken from the final database lock to a major regulatory submission (e.g., NDA, BLA) and then to market approval, compared to industry benchmarks.If the industry average for a similar drug approval is 12 months post-submission, we'd aim for 10.8 months or less. This reflects efficiency and strong regulatory relationships.Achieve submission and approval timelines within 90% of industry best-in-class benchmarks.
Clinical Development Budget AdherenceThe variance between the approved annual clinical development budget (often multi-million £) and the actual spend across the entire portfolio.If the annual budget for clinical development is £100M, actual spend should be between £95M and £105M. This shows tight financial control at an enterprise level.Maintain overall budget variance at <5% annually.
R&D Return on Investment (ROI)A high-level measure of the financial return generated from our clinical development investments, typically calculated based on projected peak sales of approved products.If we invested £500M in R&D over 5 years and the approved drugs are projected to generate £1BN in net present value, that's a 100% ROI. You're looking for strong, sustainable returns.Demonstrate a positive and increasing trend in R&D ROI year-over-year, aiming for >15%.

These are this job's own measures, with its own targets. Nothing is marked evidenced, because nobody has started this yet. Yours would fill in from the work you bring.

Your passport

This isn't a certificate you file away. It's a passport to the life you're designing.

Every credit you earn and every fluency you build adds up: evidence where it counts, carried with you. Zavmo keeps the map: where you are, where you're heading, and the next step, at your pace, around your life. From Chief Development Officer to Chief Executive Officer (CEO) of a Biotech/Pharma Company, and whatever you decide comes after.

Level 8 · in progressAI Fluency→ Chief Executive Officer (CEO) of a Biotech/Pharma Company→ your design

Where this takes you

This role is a launchpad for the highest levels of leadership in the life sciences. It's demanding, but the opportunity to leave a lasting legacy—by bringing transformative medicines to patients and building a world-class organisation—is unparalleled. We're looking for someone ready to seize that challenge.

See Your Progress GrowIllustration

Chief Development Officer

Enterprise Clinical Development Strategy
Global Regulatory Affairs & Health Authority Relations
Portfolio Risk Management
Investor Relations & Public Speaking
M&A Due Diligence & Integration

This is your Mind Palace on learn.zavmo.ai. Every skill above comes from this role's own record, not an example borrowed from another job. A node lights up when you evidence it, and what you build stays yours between jobs. That is the part a course cannot do.

14The detail, folded away

Everything else the record holds

The career branches in full, how AI is already showing up in the day-to-day, and the questions people ask about this job. Here when you want them, out of the way while you decide.

Where it leads next, rung by rung

Where it leads

The career path, and where it branches

Chief Development Officer is a start, not a ceiling. Each step below asks for new skills and hands back more autonomy.

Chief Executive Officer (CEO) of a Biotech/Pharma Company
3-7 years as CDO
Enterprise Leadership
- Full P&L accountability for the entire company
- M&A and corporate development leadership
- Public company leadership and external representation
- Legal and compliance oversight for the entire enterprise
Board Member / Non-Executive Director (NED)
Post-CDO retirement or concurrent with other roles
Governance & Oversight
- Financial literacy for board oversight
- Understanding of diverse business models and industries
- Mentorship and advisory skills for executive teams
- Crisis oversight and ethical stewardship

Working with AI on the job

Working with AI

Where AI is starting to help

Let's be real, even at the C-suite, there's always more to do than hours in the day. Imagine if you could offload some of the heavy lifting—the deep dives into market trends, the first drafts of complex reports, even prepping for those intense investor Q&As. That's where AI comes in. We're not talking about replacing your strategic brain, but giving it a serious boost.

For a Chief Development Officer, AI isn't just a fancy tool; it's a strategic partner. It helps you cut through the noise, get to insights faster, and free up your precious time for the truly critical decisions. Think of it as having a highly intelligent, always-on research and drafting assistant that helps you stay ahead of the curve in a rapidly evolving industry.

Strategic Portfolio Optimisation

Use AI models to run complex 'what-if' scenarios for our clinical pipeline. It can predict the likelihood of success for different development paths, identify optimal resource allocation across programmes, and model the financial impact of strategic pivots. This means better, faster, and more data-driven portfolio decisions.

Global Regulatory Intelligence

Leverage AI to continuously scan and analyse thousands of global regulatory documents, health authority guidance, and competitor submissions. It can flag emerging trends, predict potential regulatory hurdles for our pipeline, and identify opportunities to influence policy. Stay ahead of the curve, not just react to it.

Investor & Board Reporting

Use AI to synthesise vast amounts of clinical trial data, market intelligence, and financial projections into concise executive summaries and board presentations. It can even draft initial responses to anticipated investor questions, allowing you to refine and add your strategic insights, saving hours of prep time.

Enterprise Communication & Policy Drafting

Get AI to generate initial drafts of critical internal and external communications—think company-wide policy updates, strategic announcements, or even initial responses to media inquiries. You provide the core message, and AI handles the structure and tone, freeing you to focus on the strategic implications.

Common questions

How do you become a Chief Development Officer?

Common routes in include Internal Promotion from VP/SVP, Clinical Operations (3-5 years as VP/SVP), Chief Development Officer / Head of Clinical Development at a Smaller Biotech (5-8 years in a similar C-suite role) and Chief Medical Officer (CMO) or Senior Medical Director (if MD) (5-10 years in senior medical leadership). Times vary with prior experience.

Where can a Chief Development Officer progress to?

This role can lead on to Chief Executive Officer (CEO) of a Biotech/Pharma Company (3-7 years as CDO) and Board Member / Non-Executive Director (NED) (Post-CDO retirement or concurrent with other roles), depending on the skills you build.

What level is a Chief Development Officer in the UK?

This role aligns to RQF Level 8 on the UK framework, a guide to the depth of qualification it maps to, not a hard entry bar.

What new skills matter most for a Chief Development Officer?

Increasingly, AI-Driven Drug Development & Real-World Evidence (RWE) Integration and Decentralised Clinical Trials (DCT) at Scale & Digital Health Integration. These are the areas where the higher-paid, future-proof work is heading.

The honest bit

You’ve started things before

Most of them were built for a room full of people who aren’t you. A cohort moves on whether or not your week allowed it, and by the third week the thing you’re behind on becomes the reason you stop opening it.

There’s no cohort here, and no timetable to fall behind. Before anything starts, Zavmo asks when you’re sharpest and how long you can realistically sit down for, then builds the sessions around those answers. A bad fortnight changes your pace. It doesn’t put you behind.

And you only pay once you start learning. Searching and planning are free, and you can cancel any time — so the cost of finding out is an afternoon, not a year.

What it costs

Less than one coaching session. Every month.

A single career-coaching hour costs more than a month of this, and it ends when the hour does. Zavmo doesn't. It's £70 a month, about £2.30 a day, for a companion that knows a Chief Development Officer, works on the job you actually do, and keeps going at your pace rather than a timetable's.

Searching and planning stay free. You only pay when you start learning.
Your credits are yours. Regulated, and they don't vanish when a subscription ends.
Cancel any time and billing stops. No notice period, no minimum term.

Your path, personalised

You have the map. Walking it is the part we do together.

This route runs to 1 national skill standard. That is a real journey.

Zavmo shapes a learning experience as unique as you are. It fits how you learn, your pace and the work you already do. Every step stays benchmarked to recognised national standards. That’s the plan for becoming a Chief Development Officer: personal to you, and it still counts. The first steps are free.

Independent research finds well-designed intelligent tutoring performs nearly as well as one-to-one human tutoring: VanLehn (2011), Educational Psychologist.

A private tutor in the UK averages £35–40 an hour . Zavmo is £70/month.

A Zavmo curriculum screen: a three-month plan of nine units, ninety credits, each one an Ofqual-regulated unit the learner can tick or untick before starting. — A real plan on learn.zavmo.ai: Ofqual-regulated units, credits, and a three-month run at your own pace.

Start free No commitment. See your first steps free.

15Where to go from here

Other roles at Level 8

Same depth of qualification, different job. Useful if the work appeals but this particular role does not.

Other roles in Operations

Stay in the field you know and move sideways rather than up.

If you leave this industry

Your expertise as a CDO is highly transferable within the broader life sciences sector. You could move into leadership roles at larger pharmaceutical companies, join a venture capital firm focused on biotech, or even contribute to public health initiatives and policy-making bodies. The skills you gain here are truly global and impactful.

Not sure this is the right direction?

Work out what you actually want from work first, then come back and see which roles fit it. Takes about ten minutes.

You're not behind. You're right on time. The shift is only just beginning. Your role won't look the same in two years. Be the one who leads the change, not the one it happens to. Build my plan, free Here's the first ten minutes: a 2-minute confidence check → your personalised roadmap → meet the tutors matched to you. No card, cancel any time. No card. Build your plan, see your roadmap and meet the twelve tutors matched to you. All free. When you're ready to start learning, it's £70 a month, billed monthly. Cancel any time and billing stops.

Chief Development Officer

What's rising in its place

AI-Driven Drug Development & Real-World Evidence (RWE) Integration

Decentralised Clinical Trials (DCT) at Scale & Digital Health Integration

Skills this role draws on

Technical

How you actually get there, here

Internal Promotion from VP/SVP, Clinical Operations